Healthcare Realty Trust Incorporated (HR)
| Market Cap | 6.05B -4.6% |
| Revenue (ttm) | 1.15B -6.1% |
| Net Income | -89.65M |
| EPS | -0.26 |
| Shares Out | 346.97M |
| PE Ratio | n/a |
| Forward PE | 575.39 |
| Dividend | $0.96 (5.51%) |
| Ex-Dividend Date | Aug 11, 2026 |
| Volume | 4,628,198 |
| Open | 17.64 |
| Previous Close | 17.74 |
| Day's Range | 17.25 - 17.73 |
| 52-Week Range | 16.31 - 22.04 |
| Beta | 0.81 |
| Analysts | Hold |
| Price Target | 21.42 (+22.89%) |
| Est. Earnings | Nov 5, 2026 |
About HR
Healthcare Realty Trust Incorporated is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As of September 30, 2025, the Company was invested in 579 real estate properties in 28 states totaling 33.6 million square feet and had an enterprise value of approximately 11.1 billion dollars, defined as equity market capitalization plus the principal amount of debt le... [Read more]
Financial Performance
In 2025, Healthcare Realty Trust's revenue was $1.18 billion, a decrease of -6.93% compared to the previous year's $1.27 billion. Losses were -$248.48 million, -62.37% less than in 2024.
Financial StatementsAnalyst Summary
According to 13 analysts, the average rating for HR stock is "Hold." The 12-month stock price target is $21.42, which is an increase of 22.89% from the latest price.
News
Healthcare Realty Trust assumed with a Hold at Jefferies
Jefferies assumed coverage of Healthcare Realty Trust (HR) with a Hold rating and price target of $20, down from $21. The firm says senior housing remains its preferred way to…
Healthcare Realty Trust price target lowered to $20 from $21 at Wells Fargo
Wells Fargo lowered the firm’s price target on Healthcare Realty Trust (HR) to $20 from $21 and keeps an Equal Weight rating on the shares. The firm believes REITs will…
Healthcare Realty Trust price target raised to $22 from $21 at RBC Capital
RBC Capital raised the firm’s price target on Healthcare Realty Trust (HR) to $22 from $21 and keeps a Sector Perform rating on the shares.
Healthcare Realty Trust files to sell 36M shares of Class A common for holders
This filing relates to the offer and sale from time to time by the selling stockholders of up to 36M shares of Class A common stock. The company is not…
Healthcare Realty Trust files automatic mixed securities shelf
16:28 EDT Healthcare Realty Trust (HR) files automatic mixed securities shelf
Healthcare Realty Trust Earnings Call Transcript: Q2 2026
Operational and financial performance exceeded all strategic plan targets, with strong NOI growth, high occupancy, and robust leasing activity. Capital allocation through redevelopments and JV acquisitions is driving accretive growth, while guidance for FFO and NOI was raised again.
Healthcare Realty Trust Earnings release: Q2 2026
Healthcare Realty Trust released its Q2 2026 earnings on July 31, 2026, summarizing the period's financial results.
Healthcare Realty Trust Quarterly report: Q2 2026
Healthcare Realty Trust has published its Q2 2026 quarterly earnings report on July 31, 2026.
Healthcare Realty Trust Slides: Q2 2026
Healthcare Realty Trust has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 31, 2026.
Healthcare Realty Trust price target raised to $24 from $22 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Healthcare Realty Trust (HR) to $24 from $22 and keeps an Overweight rating on the shares. Healthcare REIT results highlight strong Senior…
Healthcare Realty Trust Registration statement: Registration filing
Healthcare Realty Trust filed a registration statement on July 31, 2026, providing details about a securities offering with the SEC.
Healthcare Realty Trust reports Q2 normalized FFO 41c, consensus 40c
Reports Q2 revenue $281.95M, consensus $267.74M. The company said, “Same store cash NOI growth of 5.1%, tenant retention of 88.5% and 4.8% cash leasing spreads. Second quarter lease executions totaled...
Healthcare Realty Reports Second Quarter 2026 Results and Further Increases Full Year 2026 Guidance
NASHVILLE, Tenn., July 30, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2026. In addition, the Company announce...
Healthcare Realty Trust Slides: Investor presentation
Healthcare Realty Trust has posted slides in relation to its latest quarterly earnings report, which was published on July 30, 2026.
Healthcare Realty Trust price target raised to $21 from $19 at JPMorgan
JPMorgan analyst Michael Mueller raised the firm’s price target on Healthcare Realty Trust (HR) to $21 from $19 and keeps a Neutral rating on the shares.
Healthcare Realty Trust price target raised to $21 from $20 at UBS
UBS raised the firm’s price target on Healthcare Realty Trust (HR) to $21 from $20 and keeps a Neutral rating on the shares.
Healthcare Realty Trust Announces Second Quarter Earnings Release Date and Conference Call
NASHVILLE, Tenn., July 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that on Thursday, July 30, 2026, after the market closes, it is scheduled to report r...
Healthcare Realty Trust resumed with an Outperform at Raymond James
Raymond James analyst David Rodgers resumed coverage of Healthcare Realty Trust (HR) with an Outperform rating and $24 price target Despite strong returns since CEO Pete Scott’s arrival, the stock…
Healthcare Realty Trust price target raised to $22 from $20 at BTIG
BTIG raised the firm’s price target on Healthcare Realty Trust (HR) to $22 from $20 and keeps a Buy rating on the shares.
Healthcare Realty Trust price target raised to $21 from $19 at RBC Capital
RBC Capital raised the firm’s price target on Healthcare Realty Trust (HR) to $21 from $19 and keeps a Sector Perform rating on the shares. The company delivered a healthy…
Healthcare Realty Trust price target raised to $20 from $18 at UBS
UBS analyst Michael Goldsmith raised the firm’s price target on Healthcare Realty Trust (HR) to $20 from $18 and keeps a Buy rating on the shares.
Healthcare Realty Trust price target raised to $22 from $20 at Scotiabank
Scotiabank raised the firm’s price target on Healthcare Realty Trust (HR) to $22 from $20 and keeps an Outperform rating on the shares. The firm raised its FFOPS estimates and…
Healthcare Realty Trust price target raised to $21 from $19 at Citi
Citi raised the firm’s price target on Healthcare Realty Trust (HR) to $21 from $19 and keeps a Neutral rating on the shares.
Healthcare Realty Announces Pricing of Upsized $600 Million Exchangeable Senior Notes Offering
NASHVILLE, Tenn., May 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE: HR) (“Healthcare Realty”) today announced that its operating partnership, Healthcare Realty Holdings, L.P...
Healthcare Realty Trust price target raised to $22 from $21 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm’s price target on Healthcare Realty Trust (HR) to $22 from $21 and keeps an Overweight rating on the shares. Healthcare Realty Trust reported solid Q1…